CN Patent

CN108348527A — 用于治疗癫痫的方法

Assigned to PTC Therapeutics Inc · Expires 2018-07-31 · 8y expired

What this patent protects

本文提供了治疗、预防、改善或管理无义突变介导的癫痫疾病的方法，所述方法包括将1,2,4‑噁二唑苯甲酸施用于患有无义突变介导的癫痫疾病的患者。具体地，本文提供了治疗、预防、改善或管理CDKL5和/或SCN1A(Dravet综合征)无义突变介导的癫痫疾病的方法。

USPTO Abstract

本文提供了治疗、预防、改善或管理无义突变介导的癫痫疾病的方法，所述方法包括将1,2,4‑噁二唑苯甲酸施用于患有无义突变介导的癫痫疾病的患者。具体地，本文提供了治疗、预防、改善或管理CDKL5和/或SCN1A(Dravet综合征)无义突变介导的癫痫疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN108348527A
Jurisdiction
CN
Classification
—
Expires
2018-07-31
Drug substance claim
No
Drug product claim
No
Assignee
PTC Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.